Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy with interferons in blood diseases.

E Polli1, A Cortelezzi

  • 1Institute of Medical Sciences, University of Milano, Italy.

Acta Haematologica
|January 1, 1987
PubMed
Summary

This study reviews clinical outcomes using interferon therapy for B and T cell neoplasms, and myeloproliferative and myelodysplastic syndromes. Interferon shows potential in treating these hematologic malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ecological risk assessment of pesticides in sediments of Pampean streams, Argentina.

Chemosphere·2022
Same author

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021
Same author

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2021
Same author

Ecotoxicology and environmental safety toxicity of pyrethroid cypermethrin on the freshwater snail Chilina parchappii: Lethal and sublethal effects.

Ecotoxicology and environmental safety·2020
Same author

IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.

Leukemia·2019
Same author

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Interferon therapy has been explored for various hematologic malignancies.
  • Understanding its clinical efficacy in specific neoplasms is crucial.

Purpose of the Study:

  • To summarize clinical experience with interferon treatment.
  • To evaluate interferon's role in B and T cell neoplasms.
  • To assess interferon's utility in myeloproliferative and myelodysplastic syndromes.

Main Methods:

  • Retrospective review of clinical data.
  • Analysis of patient outcomes following interferon administration.
  • Categorization of neoplasms into B cell, T cell, myeloproliferative, and myelodysplastic types.

Main Results:

  • Clinical experience with interferon treatment for B and T cell neoplasms was documented.
  • The study assessed interferon's effects on myeloproliferative and myelodysplastic syndromes.
  • Specific outcomes related to interferon therapy were observed.

Conclusions:

  • Interferon treatment provides a therapeutic option for certain B and T cell neoplasms.
  • Interferon demonstrates clinical relevance in managing myeloproliferative and myelodysplastic syndromes.
  • Further research may elucidate optimal interferon protocols for these conditions.

Related Experiment Videos